title: Gli1 transcriptional activity is negatively regulated by AKT2 in neuroblastoma.
abstract: Activation of the Hedgehog (Hh) signaling pathway has been implicated in a variety of malignancies including neuroblastoma. Expression of Gli1, a downstream effector of Hh, correlates with a favorable prognosis in patients with neuroblastoma. Moreover, Gli1 overexpression reduces mitotic index and induces transcription of genes involved in the differentiation of neuroblastoma cells; however, much remains unknown regarding the regulation of Gli1 transcriptional activity. Here, we report a novel negative regulation of Gli1 transcriptional activity by PI3K/AKT2 signal transduction pathway. Constitutively active PI3K subunit, p110α, inhibited Gli1 transcriptional activity in neuroblastoma cells, whereas, overexpression of an inactive form of PI3K subunit, p85, enhanced its activity. Specifically, the AKT2 isoform inhibited Gli1 luciferase activity. Silencing AKT2 using siRNA increased Gli1 transcriptional activity and conversely, overexpression of constitutively active AKT2 (myr-AKT2) decreased Gli1 transcriptional activity. Furthermore, Gli1 overexpression-mediated decrease in anchorage-independent growth was rescued by AKT2 overexpression. We also demonstrated that AKT2 overexpression regulates the nuclear-cytoplasmic distribution of exogenous Gli1 protein in neuroblastoma cells by relieving a GSK3β-mediated destabilization of SUFU, a negative regulator of Gli1 nuclear translocation. Inhibition of nuclear Gli1 accumulation may explain for the suppression of the tumor-suppressive function of Gli1. Collectively, our findings suggest an important role of Gli1 as a tumor suppressor in neuroblastoma, and offer a mechanism by which AKT2 regulates the subcellular localization, and in turn, inhibits the tumor-suppressive function of Gli1 in neuroblastoma.
authors.affiliation: Department of Pediatric Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: Pritha
authors.initials: P
authors.lastname: Paul
authors.forename: Natasha
authors.initials: N
authors.lastname: Volny
authors.forename: Sora
authors.initials: S
authors.lastname: Lee
authors.forename: Jingbo
authors.initials: J
authors.lastname: Qiao
authors.forename: Dai H
authors.initials: DH
authors.lastname: Chung
mesh_terms: D002454:Cell Differentiation / Q000502:physiology; D045744:Cell Line, Tumor; D006801:Humans; D009447:Neuroblastoma / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction; D014157:Transcription Factors / Q000235:genetics* / Q000378:metabolism; D000071676:Zinc Finger Protein GLI1
chemical_list: C400551:GLI1 protein, human; D014157:Transcription Factors; D000071676:Zinc Finger Protein GLI1; D019869:Phosphatidylinositol 3-Kinases; C494921:AKT2 protein, human; D051057:Proto-Oncogene Proteins c-akt
references.citation: J Biol Chem. 2009 Jan 23;284(4):2150-8
references.pmid: 19015273
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20315-20
references.pmid: 19075230
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12891-6
references.pmid: 18753628
references.citation: Cancer Res. 2009 Feb 15;69(4):1284-92
references.pmid: 19190345
references.citation: Oncogene. 2005 Jun 9;24(25):4026-36
references.pmid: 15806168
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11624-9
references.pmid: 14500912
references.citation: Int J Cancer. 2009 Aug 1;125(3):585-95
references.pmid: 19330838
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4505-10
references.pmid: 16537363
references.citation: J Cell Biochem. 2002;87(4):470-6
references.pmid: 14735903
references.citation: Cancer Res. 2003 Jan 1;63(1):196-206
references.pmid: 12517798
references.citation: J Biol Chem. 2007 May 11;282(19):14048-55
references.pmid: 17353198
references.citation: Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7421-6
references.pmid: 10377430
references.citation: PLoS One. 2009 Oct 16;4(10):e7491
references.pmid: 19834598
references.citation: Development. 1999 Jun;126(14):3205-16
references.pmid: 10375510
references.citation: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3438-43
references.pmid: 10725363
references.citation: Cancer Res. 2007 Jan 15;67(2):735-45
references.pmid: 17234785
references.citation: Cancer Res. 2007 Mar 1;67(5):1979-87
references.pmid: 17332325
references.citation: Mol Cell Biol. 2006 May;26(9):3365-77
references.pmid: 16611981
references.citation: J Biol Chem. 2006 Jan 6;281(1):9-12
references.pmid: 16293631
references.citation: Biochem Biophys Res Commun. 2007 Feb 9;353(2):501-8
references.pmid: 17182001
references.citation: Nat Cell Biol. 1999 Sep;1(5):312-9
references.pmid: 10559945
references.citation: J Biol Chem. 2011 Jun 3;286(22):19589-96
references.pmid: 21474452
references.citation: Oncogene. 2008 Jun 26;27(28):3999-4007
references.pmid: 18278068
references.citation: Clin Cancer Res. 2011 May 15;17(10):3233-47
references.pmid: 21355080
references.citation: Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5442-7
references.pmid: 11960000
references.citation: Science. 2004 Jun 18;304(5678):1755-9
references.pmid: 15205520
references.citation: J Pediatr Surg. 2010 Dec;45(12):2299-304
references.pmid: 21129534